Windy City Times
by Williams Institute
September 11, 2018
The Williams Institute—Only 4% of sexually active gay and bisexual men in the U.S. use Truvada as pre-exposure prophylaxis (PrEP) and 25% of young sexually active gay and bisexual men have never been tested for HIV.
The Williams Institute at UCLA School of Law finds that only 4% of sexually active gay and bisexual men in the United States use Truvada as pre-exposure prophylaxis (PrEP), which the Centers for Disease Control and Prevention regards as a highly effective tool to prevent the transmission of HIV.
In addition, researchers found that most sexually active gay and bisexual men aged 18-25 are not tested for HIV annually, as recommended by the CDC, and 25% of young men have never been tested.
"Our findings suggest that health education efforts are not adequately reaching sizable groups of men at risk for HIV infection," said the study's principal investigator Ilan H. Meyer, Distinguished Senior Public Policy Scholar at the Williams Institute. "It is alarming that high-risk populations of men who are sexually active with same-sex partners are not being tested or taking advantage of treatment advances to prevent the spread of HIV."